Compare Chromia (CHR) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chromia vs Enzyme — how do they compare? Chromia trades at Rp268.75 (market cap Rp260,43M, Rp35,16M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Chromia is the larger of the two by market cap, and Chromia's supply is capped (974,8M / 978,1M CHR (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Chromia for 50 Days and Enzyme for 28 Days on average.
| CHR | MLN | |
|---|---|---|
Market Cap | Rp260,43M | Rp134,13M |
Volume (24h) | Rp35,16M | Rp104,56M |
Circulating Supply | 974,8M / 978,1M CHR (100%) | 3,3M MLN |
Typical Hold Time | 50 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Chromia (CHR) trades at Rp268.43 with a market cap of Rp258.71M, showing neutral technical signals amid bearish moving averages. The token is fully circulated with a 50-day average hold time. Key support lies at Rp265 and resistance at Rp285. Recent ecosystem updates include mainnet progress and dApp integrations, though no major protocol upgrades were reported in the last month.
Outlook remains neutral with opportunities in blockchain adoption growth, but risks include high volatility and regulatory uncertainty. Investors should monitor trading volume trends and network activity for directional cues.
Enzyme (MLN) shows a market cap of Rp134,13M with a circulating supply of 3,3jt tokens. The asset's price data is currently unavailable, but the hold time of 28 days suggests moderate trader retention. Recent news on ETF inflows may indirectly affect crypto sentiment, though no direct protocol updates are noted. Trading volumes and network activity metrics require verification from live crypto data sources for a complete picture.
Outlook: Enzyme faces typical crypto volatility risks with limited recent fundamental developments. Opportunities may arise from broader market trends, but investors should monitor liquidity and regulatory shifts closely. Major risks include low market cap susceptibility to manipulation and absence of max supply clarity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Chromia
Chromia is a standalone Layer-1 blockchain and EVM compatible Layer-2 enhancement for Binance Smart Chain and Ethereum. It is designed to enhance existing dApps and allow for the creation of next-generation dApps by providing scalability, improved data handling, and customizable fee structures. The blockchain uses a unique architecture called relational blockchain, as well as a custom programming language called Rell.
Read more on CHR →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
